13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 33 holding rows worth $191,991,000.
- Accession
- 0001420506-22-001695
- Filer
- CIK 1595851
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 34 entries on the cover page, a total value of $191,991,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $191,991,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 400,000 | $29,708,000 | thousands by filing date | put |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 400,000 | $10,784,000 | thousands by filing date | call |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,000,000 | $10,740,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 225,000 | $10,175,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 130,000 | $9,745,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 225,000 | $8,618,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 900,000 | $8,118,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 100,000 | $7,976,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 110,000 | $7,384,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 325,000 | $7,072,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 75,000 | $6,972,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 600,000 | $6,942,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 35,000 | $6,193,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 45,000 | $5,693,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 250,000 | $5,660,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 500,000 | $4,810,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 800,000 | $4,776,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 250,000 | $4,748,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 110,000 | $4,630,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 225,000 | $4,329,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 275,000 | $3,850,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 450,000 | $3,722,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 50,000 | $3,714,000 | thousands by filing date | call |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 325,000 | $3,439,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 165,000 | $3,011,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 150,000 | $2,328,000 | thousands by filing date | call |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 150,000 | $1,848,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 120,000 | $1,752,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 300,000 | $1,575,000 | thousands by filing date | |
| 9 METERS BIOPHARMA INC | 654405109 | COM | 1,800,000 | $469,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 925,000 | $467,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 30,000 | $466,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,900 | $277,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-22-001695 | this filing | 2022-08-15 | acceptance time not in the bulk data set |